Other
Evolve All-in-One UltraYield ETF Expected to Begin Trading on March 12, 2026

EASY · Price
Executive Summary
- Evolve Funds Group Inc. filed a final prospectus for the Evolve All‑in‑One UltraYield ETF (TSX: EASY), slated to begin trading on the Toronto Stock Exchange on March 12, 2026.
- EASY will provide modestly levered exposure to a portfolio of three existing Evolve UltraYield ETFs (BIGY, CANY, INTY) and employ a covered‑call strategy with cash distributions paid at least twice per month.
- The fund carries a 0% management fee (underlying funds charge 0.40%–0.60%); leverage will be achieved via cash borrowings and/or derivatives.
Key Details
- Fund Name & Ticker: Evolve All‑in‑One UltraYield ETF – ticker EASY (CAD‑hedged ETF units).
- Trading Commencement: Expected to start trading on the TSX on 2026‑03‑12, subject to exchange approval.
- Structure: Combines three existing UltraYield ETFs:
- Evolve US Equity UltraYield ETF (BIGY) – management fee 0.40% of NAV + taxes.
- Evolve Canadian Equity UltraYield ETF (CANY) – management fee 0.40% of NAV + taxes.
- Evolve International Equity UltraYield ETF (INTY) – management fee 0.60% of NAV + taxes.
- Investment Objective: Provide attractive income and long‑term capital appreciation through a diversified portfolio of global equities that generate option premiums via a covered‑call program.
- Leverage: Modest leverage to be employed using cash borrowings and/or derivatives, as permitted under securities legislation.
- Distribution Frequency: Cash distributions intended to be paid at least twice per month (potential for more frequent payouts).
- Management Fee: 0% on EASY itself; underlying funds’ fees apply as noted above.
- Regulatory Status: Final prospectus filed; awaiting TSX approval before launch.
Notable Quotes
“We are excited to expand Evolve's UltraYield ETFs lineup, which is designed to deliver enhanced income twice per month,” – Raj Lala, President and CEO, Evolve Funds Group Inc.
All forward‑looking statements are subject to risks and uncertainties; actual results may differ.